Posted in | News | Ceramic Materials | Business | Aluminum / Aluminium

Rusal Purchase Controlling Interest in Italian EurAllumina Refinery

Nov 3 2006

Related Stories

RUSAL, a top-three global aluminium producer, announces the successful completion of an agreement with Rio Tinto to purchase a 56.2% stake in the EurAllumina alumina refinery in Italy.

The remaining 43.8% share of EurAllumina is owned by Glencore. Ownership of the asset will be consolidated under United Company RUSAL, when the merger of RUSAL, SUAL and Glencore's alumina assets is completed next year.

Commenting on the acquisition of the EurAllumina refinery, Alexander Bulygin, RUSAL's CEO, said: «The acquisition of this stake is an important step in the consolidation of Euroallumina into United Company RUSAL. EurAllumina will provide an additional annual input of 600,000 tonnes of alumina.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback